M&A Deal Summary

ICON Acquires Clinical Research Management

On June 30, 2016, ICON acquired life science company Clinical Research Management

Acquisition Highlights
  • This is ICON’s 13th transaction in the Life Science sector.
  • This is ICON’s 15th transaction in the United States.
  • This is ICON’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2016-06-30
Target Clinical Research Management
Sector Life Science
Buyer(s) ICON
Deal Type Add-on Acquisition

Target

Clinical Research Management

Agawam, Massachusetts, United States
Clinical Research Management, Inc. is a provider of full service and functional research solutions to a broad range of US government agencies. Their extensive expertise extends across basic and applied research, infectious diseases, vaccines development and testing and the response to bio-threats. They have worked in collaboration with government and commercial customers to respond to the threat of global viral epidemics.

Search 205,905 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ICON

Dublin, Ireland

Category Company
Founded 1990
Sector Life Science
Employees41,100
Revenue 8.1B USD (2023)
DESCRIPTION

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. ICON was founded in 1990 and is based in Dublin, Ireland.


DEAL STATS #
Overall 23 of 29
Sector (Life Science) 13 of 16
Type (Add-on Acquisition) 19 of 25
State (Massachusetts) 1 of 1
Country (United States) 15 of 18
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-12-07 PMG Research

Winston-Salem, North Carolina, United States

PMG Research, Inc. is an integrated network of clinical research company.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-27 Mapi Group

Lyon, France

Mapi Group is a provider of health research and commercialization services to life-science companies enabling market authorization, market access and market adoption of novel therapeutics. Mapi is based in Lyon, France.

Buy -